Quality assurance of conventional non-CT-based internal mammary lymph node irradiation in a prospective Danish Breast Cancer Cooperative Group trial: The DBCG-IMN study

Acta Oncologica

Volumn 52, Issue 7, 2013, Pages 1526-1534

  Thorsen, Lise B J ^a   Thomsen, Mette S ^a   Overgaard, Marie ^a   Overgaard, Jens ^a   Offersen, Birgitte V ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DENMARK; HUMAN; LUNG; LYMPH NODE IRRADIATION; LYMPH NODE METASTASIS; MEDICAL DEVICE; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY CONTROL; RADIATION DOSE; SIMULATION; TREATMENT PLANNING; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; CONVENTIONAL NON COMPUTER ASSISTED TOMOGRAPHY; DANISH CITIZEN; INTERNAL MAMMARY LYMPH NODE IRRADIATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; ORGANS AT RISK; RADIATION DOSE DISTRIBUTION; SIXTH CERVICAL VERTEBRA; THORAX WALL; TUMOR VOLUME;

ALGORITHMS; BREAST NEOPLASMS; DENMARK; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC IRRADIATION; MONTE CARLO METHOD; NEOPLASM STAGING; ORGANS AT RISK; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY ASSURANCE, HEALTH CARE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, ADJUVANT; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84884554756     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2013.813643     Document Type: Article

References (28)

1. Huang O, Wang L, Shen K, Lin H, Hu Z, Liu G, et al. Breast cancer subpopulation with high risk of internal mammary lymph nodes metastasis: Analysis of 2,269 Chinese breast cancer patients treated with extended radical mastectomy. Breast Cancer Res Treat 2008;107:379-87
2. Dahl-Iversen E, Tobiassen T. R adical mastectomy with parasternal and supraclavicular dissection for mammary carcinoma . Ann Surg 1969;170:889-91
3. Meier P, Ferguson DJ, Karrison T. A controlled triaLof extended radical versus radical mastectomy. Ten-year results. Cancer 1989;63:188-95
4. Overgaard M, Hansen P S, Overgaard J, Rose C, Andersson M, Bach F, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997;337:949-55
5. Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999;353:1641-8
6. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 2005;366:2087-106
7. Arriagada R, Le M G, Mouriesse H, Fontaine F, Dewar J, Rochard F, et al. Long-term effect of internal mammary chain treatment. Results of a multivariate analysis of 1195 patients with operable breast cancer and positive axillary nodes. Radiother Oncol 1988;11:213-22
8. Olson RA, Woods R, Speers C, Lau J, Lo A, Truong PT, et al. Does the intent to irradiate the internal mammary nodes impact survivaLin women with breast cancer? A populationbased analysis in British Columbia. Int J Radiat Oncol Biol Phys 2012;83:e35-e41
9. Kaija H, Maunu P. T angential breast irradiation with or without internal mammary chain irradiation: Results of a randomized trial. Radiother Oncol 1995;36:172-6
10. Musat E, Poortmans P, Van Den Bogaert W, Struikmans H, Fourquet A, Bartelink H, et al. Quality assurance in breast cancer: EORTC experiences in the phase III triaLon irradiation of the internal mammary nodes. Eur J Cancer 2007;43:718-24
11. Overgaard M, Christensen J J. Postoperative radiotherapy in DBCG during 30 years. Techniques, indications and clinical radiobiologicaLexperience. Acta Oncol 2008;47:639-53
12. Nielsen HM, Christensen JJ, Aagaard T, Thingholm J, Overgaard M, Grau C. A simple method to test if the internal mammary lymph nodes are covered by the wide tangent technique in radiotherapy for high-risk breast cancer. Clin Oncol (R Coll Radiol) 2003;15:17-24
13. Nielsen M H, Berg M, Pedersen AN, Andersen K, Glavicic V, Jakobsen EH, et al. Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: National guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group. Acta Oncol 2013
14. Poortmans P, Kouloulias VE, Venselaar JL, Struikmans H, Davis JB, Huyskens D, et al. Quality assurance of EORTC trial 22922/10925 investigating the role of internal mammary-medial supraclavicular irradiation in stage I-III breast cancer: The individual case review. Eur J Cancer 2003;39:2035-42
15. Vikstrom J, Hjelstuen M H, Mjaaland I, Dybvik K I. Cardiac and pulmonary dose reduction for tangentially irradiated breast cancer, utilizing deep inspiration breath-hold witHaudio-visual guidance, without compromising target coverage . Acta Oncol 2011;50:42-50
16. Johansen S, Vikstrom J, Hjelstuen M H, Mjaaland I, Dybvik KI, Olsen DR. Dose evaluation and risk estimation for secondary cancer in contralateral breast and a study of correlation between thorax shape and dose to organs at risk following tangentially breast irradiation during deep inspiration breath-hold and free breathing. Acta Oncol 2011;50:563-8
17. Grantzau T, Mellemkjaer L, Overgaard J. Second primary cancers after adjuvant radiotherapy in early breast cancer patients: A national population based studYunder the Danish Breast Cancer Cooperative Group (DBCG). Radiother Oncol 2013;106:42-9
18. Lundstedt D, Gustafsson M, Steineck G, Alsadius D, Sundberg A, WilderanGu, et al. Long-term symptoms after radiotherapy of supraclavicular lymph nodes in breast cancer patients. Radiother Oncol 2012;103:155-60
19. Lyngholm CD, Christiansen PM, Damsgaard TE, Overgaard J. Long-term follow-up of late morbidity, cosmetic outcome and body image after breast conserving therapy. A study from the Danish Breast Cancer Cooperative Group (DBCG). Acta Oncol 2013;52:259-69
20. Thomsen MS, Berg M, Nielsen HM, Pedersen AN, Overgaard M, Ewertz M, et al. Post-mastectomy radiotherapy in Denmark: From 2D to 3D treatment planning guidelines of The Danish Breast Cancer Cooperative Group. Acta Oncol 2008;47:654-61
21. Das IJ, Andrews J Z, Cao M, Johnstone P A. Correlation of 2D parameters to lung and heart dose-volume in radiation treatment of breast cancer. Acta Oncol 2013;52:178-83
22. Arthur DW, Arnfield MR, WarwickElA, Morris MM, Zwicker RD. Internal mammary node coverage: An investigation of presently accepted techniques. Int J Radiat Oncol Biol Phys 2000;48:139-46
23. Matzinger O, Heimsoth I, Poortmans P, CollettEl, Struikmans H, Van Den Bogaert W, et al. Toxicity at three years witHand without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925). Acta Oncol 2010;49:24-34
24. Taylor C W, Bronnum D, Darby S C, Gagliardi G, Hall P, Jensen MB, et al. Cardiac dose estimates from DanisHand Swedish breast cancer radiotherapy during 1977-2001. Radiother Oncol 2011;100:176-83
25. Hojris I, Overgaard M, Christensen JJ, Overgaard J. Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: Analysis of DBCG 82b and 82c randomised trials. Radiotherapy Committee of the Danish Breast Cancer Cooperative Group. Lancet 1999;354:1425-30
26. Andratschke N, Maurer J, Molls M, Trott KR. Late radiation-induced heart disease after radiotherapy. ClinicaLimportance, radiobiological mechanisms and strategies of prevention. Radiother Oncol 2011;100:160-6
27. McGale P, Darby S C, Hall P, Adolfsson J, Bengtsson NO, Bennet AM, et al. Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. Radiother Oncol 2011;100:167-75
28. Dijkema IM, Hofman P, Raaijmakers C P, Lagendijk JJ, Battermann JJ, Hillen B. Loco-regional conformal radiotherapy of the breast: Delineation of the regional lymph node clinical target volumes in treatment position. Radiother Oncol 2004;71:287-95